COVID-19 and Cardiovascular Diseases
- PMID: 33973184
- DOI: 10.1007/978-3-030-63761-3_16
COVID-19 and Cardiovascular Diseases
Abstract
We herein seek to expound on up-to-the-minute information regarding cardiovascular disease in the era of coronavirus disease 2019 (COVID-19) by highlighting acute myocardial injury caused by COVID-19 and probing into its pathophysiology, clinical signs, diagnostic tests, and treatment modalities. We aim to share the latest research findings vis-à-vis cardiovascular disease patients with confirmed or suspected COVID-19 on the association between hypertension and this infectious disease along with the relevant recommendations; describe the mechanism of coronary artery disease in such patients together with the necessary measures in the setting of non-ST-segment elevation acute coronary syndrome, ST-segment elevation myocardial infarction, and chronic coronary syndrome; discuss tachy- and bradyarrhythmias in the COVID-19 setting alongside their treatments; elucidate coagulopathies, venous thromboembolism, and its prophylactic measures in the context of this infection; set out the cardiopulmonary resuscitation protocol as well as the pertinent safety concerns during the current pandemic; and, finally, explicate drug-drug interactions between COVID-19 and cardiovascular medication in hypertension, acute coronary syndrome, heart failure, venous thromboembolism, and arrhythmias.
Keywords: COVID-19; Cardiovascular disease; Outbreak; SARS-CoV-2.
Similar articles
-
Management of acute cardiovascular events in patients with COVID-19.Rev Cardiovasc Med. 2020 Dec 30;21(4):577-581. doi: 10.31083/j.rcm.2020.04.140. Rev Cardiovasc Med. 2020. PMID: 33388002 Review.
-
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14. Circ Cardiovasc Interv. 2020. PMID: 32791953
-
COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.Cardiovasc Revasc Med. 2020 Aug;21(8):946-949. doi: 10.1016/j.carrev.2020.05.009. Epub 2020 May 15. Cardiovasc Revasc Med. 2020. PMID: 32423791 Free PMC article.
-
Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.Circulation. 2021 Mar 9;143(10):1031-1042. doi: 10.1161/CIRCULATIONAHA.120.051828. Epub 2021 Jan 22. Circulation. 2021. PMID: 33480806
-
Cardiovascular system and COVID-19: perspectives from a developing country.Monaldi Arch Chest Dis. 2020 May 7;90(2). doi: 10.4081/monaldi.2020.1305. Monaldi Arch Chest Dis. 2020. PMID: 32380802 Review.
References
-
- Abdi S, Salarifar M, Mortazavi SH, Sadeghipour P, Geraiely B (2020) COVID-19 sends STEMI to quarantine!? Clin Res Cardiol:1–2. https://doi.org/10.1007/s00392-020-01664-3
-
- Alhogbani T (2016) Acute myocarditis associated with novel middle east respiratory syndrome coronavirus. Ann Saudi Med 36(1):78–80. https://doi.org/10.5144/0256-4947.2016.78 - DOI - PubMed - PMC
-
- American Society of Transplantation. COVID-19 (Coronavirus): FAQs for organ transplantation. Updated February 29, 2020. Available from: https://www.myast.org/sites/default/files/COVID19%20FAQ%20Tx%20Centers%2...
-
- Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, Chadow HL, Fishman GI, Reynolds HR, Keller N, Hochman JS (2020) ST-segment elevation in patients with Covid-19 – a case series. N Engl J Med. https://doi.org/10.1056/NEJMc2009020
-
- Barati S, Garjani K, Payandemehr P, Totonchi Z, Zanganehfar ME, Sadeghipour P, Amin A, Akhondi V, Javadi AM, Sadeghipour P (2020) Iranian heart association task force on cardiopulmonary resuscitation guidelines on the COVID-19 outbreak. Res Cardiovasc Med 9(1):3–5. https://doi.org/10.4103/rcm.rcm_10_20 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous